(Unaudited)
Amounts in billions, except per share amounts
Net Sales
2022 | 2021 | 2020 | 2019 | 2018 |
$80.2 | $76.1 | $71.0 | $67.7 | $66.8 |
Operating Income
2022 | 2021 | 2020 | 2019 | 2018 |
$17.8 | $18.0 | $15.7 | $5.5 | $13.4 |
Net Earnings Attributable to P&G
2022 | 2021 | 2020 | 2019 | 2018 |
$14.7 | $14.3 | $13.0 | $3.9 | $9.8 |
Net Earnings Margin from Continuing Operations
2022 | 2021 | 2020 | 2019 | 2018 |
18.4% | 18.9% | 18.5% | 5.9% | 14.8% |
Diluted Net Earnings per Common Share from Continuing Operations 1
2022 | 2021 | 2020 | 2019 | 2018 |
$5.81 | $5.50 | $4.96 | $1.43 | $3.67 |
Diluted Net Earnings per Common Share1
2022 | 2021 | 2020 | 2019 | 2018 |
$5.81 | $5.50 | $4.96 | $1.43 | $3.67 |
Core Earnings per Share2
2022 | 2021 | 2020 | 2019 | 2018 |
$5.81 | $5.66 | $5.12 | $4.52 | $4.22 |
Operating Cash Flow
2022 | 2021 | 2020 | 2019 | 2018 |
$16.7 | $18.4 | $17.4 | $15.2 | $14.9 |
Dividends per Common Share
2022 | 2021 | 2020 | 2019 | 2018 |
$3.52 | $3.24 | $3.03 | $2.90 | $2.79 |
2022 NET SALES BY
BUSINESS SEGMENT3
Fabric & Home Care | 35% | |
Baby, Feminine & Family Care | 25% | |
Beauty | 18% | |
Health Care | 14% | |
Grooming | 8% |
2022 NET SALES BY
GEOGRAPHIC REGION
North America4 | 49% | |
Europe | 21% | |
Greater China | 10% | |
Asia Pacific | 8% | |
Latin America | 6% | |
India, Middle East | 6% |
(1) Diluted net earnings per common share are calculated based on net earnings attributable to Procter & Gamble.
(2) Core EPS is a measure of the Company’s diluted net earnings per common share from continuing operations adjusted for certain items not viewed as part of our sustainable results. Please see page 74 of the Annual Report for detail on the reconciling items.
(3) These results exclude net sales in Corporate.
(4) North America includes the United States, Canada and Puerto Rico.
Please see Measures Not Defined by U.S. GAAP in the Downloads section, or page 74 of the print Annual Report, for definitions of non-GAAP measures and reconciliations to the most closely related GAAP measure.
VARIOUS STATEMENTS IN THIS ANNUAL REPORT, including estimates, projections, objectives and expected results, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are generally identified by the words “believe,” “expect,” “anticipate,” “intend,” “opportunity,” “plan,” “project,” “will,” “should,” “could,” “would,” “likely” and similar expressions. Forward-looking statements are based on current assumptions that are subject to risks and uncertainties that may cause actual results to differ materially from the forward-looking statements, including the risks and uncertainties discussed in Item 1A – Risk Factors of the Form 10-K included in this Annual Report. Such forward-looking statements speak only as of the date they are made, and we undertake no obligation to update or revise publicly any forward-looking statements, except as required by law.
Brand names referenced in this Annual Report are trademarks of The Procter & Gamble Company or one of its subsidiaries. All other brand names are trademarks of their respective owners.